February 23, 2024 • 00:07:55

Lotilaner Ophthalmic Solution, 0.25%, for Treatment of Demodex Blepharitis: Trial Results (Saturn-1)

Lotilaner Ophthalmic Solution, 0.25%, for the Treatment of Demodex Blepharitis: Results of a Prospective, Randomized, Vehicle-Controlled, Double-Masked, Pivotal Trial (Saturn-1) Hosted By: Andrew Pucker, OD, PhD, FAAO Topical Editor: Andrew Pucker, OD, PhD, FAAO Topical Expert: Patrick Vollmer - Tarsus Article: https://pubmed.ncbi.nlm.nih.gov/35965392/

No transcript available.